000 01070 a2200289 4500
005 20250513230329.0
264 0 _c20010301
008 200103s 0 0 eng d
022 _a1434-6621
024 7 _a10.1515/CCLM.2000.190
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTolou-Ghamari, Z
245 0 0 _aIn vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation.
_h[electronic resource]
260 _bClinical chemistry and laboratory medicine
_cNov 2000
300 _a1209-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers
650 0 4 _aDrug Monitoring
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLiver Transplantation
650 0 4 _aTacrolimus
_xtherapeutic use
700 1 _aWendon, J
700 1 _aTredger, J M
773 0 _tClinical chemistry and laboratory medicine
_gvol. 38
_gno. 11
_gp. 1209-11
856 4 0 _uhttps://doi.org/10.1515/CCLM.2000.190
_zAvailable from publisher's website
999 _c11096017
_d11096017